Companies in the oncology sector developing innovative solutions and technologies.
Explore 303 recently funded oncology companies with verified founder contact information and fundraising data.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.
Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.
We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.
Solstice Health is an AI life sciences marketing platform that offers a clinical data retrieval platform for oncology practice.
Triomics is a generative AI-powered platform that matches patients to clinical trials.
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Hornet Therapeutics provides immune cell metabolism & cell therapy for cancer treatment.
Hemerion is focused on creating innovative cancer treatments.
OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
iCellate is a Swedish research and development company focused on cancer research and detection products.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 303 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked